Campbell Wealth Management Eli Lilly & CO Transaction History

Campbell Wealth Management

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 09, 2024	SELL	$592.2 - $792.28 $50,337 - $67,343	-85 Reduced 3.34%	2,462 $1.92 Million
Q4 2023 Feb 08, 2024	BUY	$525.19 - $619.13 $905,427 - $1.07 Million	1,724 Added 209.48%	2,547 $1.49 Million
Q3 2023 Nov 13, 2023	BUY	$434.7 - $599.3 $27,386 - $37,755	63 Added 8.29%	823 $442,000
Q2 2023 Jul 31, 2023	BUY	$350.74 - $468.98 $266,562 - $356,424	760 New	760 $356,000
Q1 2023 May 08, 2023	SELL	$310.63 - $364.82 $3,106 - $3,648	-10 Reduced 1.3%	760 $261,000
Q4 2022 Jan 10, 2023	SELL	$321.55 - $374.67 $1,286 - $1,498	-4 Reduced 0.52%	770 $282,000
Q3 2022 Oct 11, 2022	BUY	$296.48 - $337.87 $229,475 - $261,511	774 New	774 $250,000
Q2 2022 Aug 02, 2022	SELL	$278.73 - $327.27 $211,834 - $248,725	-760 Closed	0 $0
Q4 2021 Jan 27, 2022	BUY	$224.85 - $279.04 $170,886 - $212,070	760 New	760 $210,000
Q3 2020 Nov 02, 2020	SELL	$146.22 - $169.13 $111,127 - $128,538	-760 Closed	0 $0
Q2 2020 Jul 23, 2020	BUY	$136.42 - $164.18 $103,679 - $124,776	760 New	760 $125,000

3,872

751M

6.34M

7.97M

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $842B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

Get notified when there are updates to the investment portfolio of Campbell Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Campbell Wealth Management with notifications on news.